Evidence map›Paper›PMID 41310345›Full record

ArticleScientific reports2025

A novel framework using particle swarm optimization and long short-term memory networks for stock market forcasting.

MohammadEsmael Heidari Safari, Soodeh Hosseini

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

MohammadEsmael Heidari SafariDepartment of Computer Science, Faculty of Mathematics and Computer, Shahid Bahonar University of Kerman, Kerman, Iran.
Soodeh HosseiniDepartment of Computer Science, Faculty of Mathematics and Computer, Shahid Bahonar University of Kerman, Kerman, Iran. so_hosseini@uk.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate stock price forecasting remains a challenging task due to the complex, nonlinear, and sentiment-driven nature of financial markets. This study presents an intelligent hybrid framework that integrates long-short-term memory (LSTM) networks with metaheuristic optimization and financial sentiment analysis to improve stock price forecasting. Initially, three single-layer, two-layers, and three-layer LSTM architectures are evaluated using fixed parameters, showing that deeper networks do not always perform better without proper tuning. Three nature-inspired algorithms, particle swarm optimization (PSO), gray wolf optimization (GWO), and artificial rabbit optimization (ARO), are used to optimize the model configurations. Experimental results showed that PSO consistently outperformed other techniques in all evaluation metrics (RMSE, MAE, R², MAPE). In the final stage, sentiment features extracted from economic news are integrated into the input data using the FinBERT model. The resulting hybrid model, SEN_PSO_LSTM, achieved superior forecasting performance on the four major stocks Apple, Amazon, Google, and Microsoft, as well as three others from diverse industries, including JPMorgan Chase in the financial sector, UnitedHealth Group in healthcare, and Toyota Motor in the automotive industry.The findings confirm that combining deep learning with hyperparametric optimization and sentiment analysis significantly improves forecasting accuracy under volatile market conditions.

Indexed as

Artificial rabbit optimization (ARO)Financial newsGray wolf optimization (GWO)Long-short-term memory (LSTM)Particle swarm optimization (PSO)Sentiment analysisStock market prediction

Identifiers

PMID41310345
PMCPMC12663550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.